Fisher Asset Management LLC Has $676,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Fisher Asset Management LLC decreased its stake in Teleflex Incorporated (NYSE:TFX) by 26.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,711 shares of the medical technology company’s stock after selling 983 shares during the period. Fisher Asset Management LLC’s holdings in Teleflex were worth $676,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in TFX. Rafferty Asset Management LLC boosted its position in shares of Teleflex by 6.8% during the 3rd quarter. Rafferty Asset Management LLC now owns 4,910 shares of the medical technology company’s stock valued at $964,000 after purchasing an additional 314 shares in the last quarter. QRG Capital Management Inc. bought a new stake in shares of Teleflex during the 3rd quarter valued at about $214,000. Envestnet Portfolio Solutions Inc. bought a new stake in shares of Teleflex during the 3rd quarter valued at about $277,000. Envestnet Asset Management Inc. boosted its position in shares of Teleflex by 53.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 51,765 shares of the medical technology company’s stock valued at $10,167,000 after purchasing an additional 18,015 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Teleflex by 4.3% during the 3rd quarter. Northern Trust Corp now owns 457,170 shares of the medical technology company’s stock valued at $89,793,000 after purchasing an additional 19,001 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Truist Financial reduced their price objective on Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research note on Friday, May 3rd. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and a consensus target price of $257.29.

Teleflex Price Performance

TFX opened at $203.40 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.51 and a quick ratio of 1.41. The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of 32.65, a P/E/G ratio of 1.96 and a beta of 1.16. The firm’s fifty day moving average price is $208.37 and its two-hundred day moving average price is $227.11. Teleflex Incorporated has a 1 year low of $177.63 and a 1 year high of $262.97.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.07 by $0.14. The firm had revenue of $737.80 million for the quarter, compared to the consensus estimate of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.09 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.75 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date was Tuesday, May 14th. Teleflex’s payout ratio is 21.83%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.